BioMaxima S.A. (WSE:BMX)
Poland · Delayed Price · Currency is PLN 8.71
-0.59 (-6.34%)
Nov 4, 2026, 1:06 PM CET
BioMaxima Revenue
BioMaxima had revenue of 13.80M PLN in the quarter ending June 30, 2026, with 6.95% growth. This brings the company's total for the last twelve months to 60.64M, up 6.30% year-over-year. In the year 2025, BioMaxima had annual revenue of 60.90M with 15.24% growth. That makes BioMaxima the 35,277th largest company in the world by revenue and 308th in Poland.
Revenue (ttm)
60.64M
Revenue Growth
+6.30%
P/S Ratio
0.64
Revenue / Employee
424.04K
Employees
143
Market Cap
36.52M
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full BioMaxima breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 60.90M | 8.05M | 15.24% |
| Dec 31, 2024 | 52.85M | 6.07M | 12.96% |
| Dec 31, 2023 | 46.79M | -97.08M | -67.48% |
| Dec 31, 2022 | 143.87M | 64.78M | 81.91% |
| Dec 31, 2021 | 79.09M | 16.10M | 25.56% |
| Dec 31, 2020 | 62.99M | 32.52M | 106.70% |
| Dec 31, 2019 | 30.47M | -2.61M | -7.90% |
| Dec 31, 2018 | 33.09M | 131.31K | 0.40% |
| Dec 31, 2017 | 32.96M | 4.21M | 14.64% |
| Dec 31, 2016 | 28.75M | 5.66M | 24.52% |
| Dec 31, 2015 | 23.08M | 1.44M | 6.64% |
| Dec 31, 2014 | 21.65M | -169.64K | -0.78% |
| Dec 31, 2013 | 21.82M | -693.86K | -3.08% |
| Dec 31, 2012 | 22.51M | 12.00M | 114.14% |
| Dec 31, 2011 | 10.51M | 3.32M | 46.25% |
| Dec 31, 2010 | 7.19M | 507.17K | 7.59% |
| Dec 31, 2009 | 6.68M | 471.00K | 7.58% |
| Dec 31, 2008 | 6.21M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 14.14B |
| Diagnostyka | 2.58B |
| Synektik Spólka Akcyjna | 932.97M |
| Voxel | 640.61M |
| Biogened | 110.11M |
| Genomed Spólka Akcyjna | 30.64M |
| MedApp | 6.75M |
| Pharmena | 1.46M |